Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hyaluronidase ameliorates rejection-induced edema.

C Johnsson1, R Hällgren, A Elvin

  • 1Department of Transplantation Surgery, University Hospital, S-751 85 Uppsala, Sweden. Cecilia.Johnsson@kirurgi.uu.se

Transplant International : Official Journal of the European Society for Organ Transplantation
|August 26, 1999
PubMed
Summary

Hyaluronidase treatment reduced fluid buildup and improved organ transplant survival. This enzyme breaks down hyaluronan, a molecule that causes swelling in rejecting organs, offering a potential therapy for post-transplant edema.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Co-designing interprofessional education in primary healthcare: an illustration from the Make My Day stroke prevention project.

Journal of interprofessional care·2025
Same author

Kinematic and kinetic analysis of the inter- and intra-applicator assessment of the Babinski reflex.

Neurophysiologie clinique = Clinical neurophysiology·2014
Same author

Initial experience with hypothermic machine perfusion of kidneys from deceased donors in the Uppsala region in Sweden.

Transplantation proceedings·2013
Same author

Obtaining regulatory T cells from uraemic patients awaiting kidney transplantation for use in clinical trials.

Clinical and experimental immunology·2013
Same author

Long term health-related quality of life after burns is strongly dependent on pre-existing disease and psychosocial issues and less due to the burn itself.

Burns : journal of the International Society for Burn Injuries·2013
Same author

Transplant co-ordination services in Europe 1989: a survey by the EDTA Registry.

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association·2013

Area of Science:

  • Biochemistry
  • Immunology
  • Transplantation Medicine

Background:

  • Hyaluronan (HA), a glycosaminoglycan, accumulates in interstitial edematous tissue during organ transplant rejection.
  • This accumulation contributes to increased tissue water content and edema in rejecting allografts.

Purpose of the Study:

  • To investigate if hyaluronidase, an enzyme that degrades hyaluronan, can prevent or reduce edema and improve outcomes in a rat heart transplantation model.
  • To evaluate the efficacy of hyaluronidase therapy, alone or with cyclosporine, in managing allograft rejection-associated edema and graft survival.

Main Methods:

  • Heterotopic heart transplantations were performed between PVG and Wistar/Kyoto rats.
  • Recipient rats received prophylactic or therapeutic treatment with hyaluronidase, with or without cyclosporine.

Related Experiment Videos

  • Cardiac hyaluronan and water content were measured, and graft morphology and survival were assessed.
  • Main Results:

    • Daily intravenous hyaluronidase significantly reduced cardiac hyaluronan and water content by day six post-transplantation.
    • Hyaluronidase treatment led to better graft morphology and reduced mononuclear cell infiltration compared to controls.
    • Both prophylactic and therapeutic hyaluronidase, alone or combined with cyclosporine, prolonged graft survival times.
    • A two-hour hyaluronidase infusion also reduced established edema five days after transplantation.

    Conclusions:

    • Hyaluronan accumulation is critical in post-organ transplantation edema formation.
    • Hyaluronidase therapy is a viable strategy to reduce edema and potentially improve outcomes after organ transplantation.